1. Evolution in the treatment of gastroenteropancreatic-neuroendocrine neoplasms, focus on systemic therapeutic options: a systematic review. (July 2015) Authors: Pusceddu, Sara; De Braud, Filippo; Festinese, Fabrizio; Bregant, Cristina; Lorenzoni, Alice; Maccauro, Marco; Milione, Massimo; Concas, Laura; Formisano, Barbara; Leuzzi, Livia; Mazzaferro, Vincenzo; Buzzoni, Roberto Journal: Future oncology Issue: Volume 11:Number 13(2015) Page Start: 1947 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes. (May 2016) Authors: Pusceddu, Sara; Buzzoni, Roberto; Vernieri, Claudio; Concas, Laura; Marceglia, Sara; Giacomelli, Luca; Milione, Massimo; Leuzzi, Livia; Femia, Daniela; Formisano, Barbara; Mazzaferro, Vincenzo; de Braud, Filippo Journal: Future oncology Issue: Volume 12:Number 10(2016) Page Start: 1251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Rationale and protocol of the MetNET-1 trial, a prospective, single center, phase II study to evaluate the activity and safety of everolimus in combination with octreotide LAR and metformin in patients with advanced pancreatic neuroendocrine tumors. Issue 6 (November 2014) Authors: Pusceddu, Sara; de Braud, Filippo; Concas, Laura; Bregant, Cristina; Leuzzi, Livia; Formisano, Barbara; Buzzoni, Roberto Journal: Tumori Issue: Volume 100:Issue 6(2014) Page Start: e286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗